News Column

Premier Diagnostic Health Services Inc. - Private Placement Extended

Apr 3 2013 12:00AM

Marketwire

LogoTracker

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/03/13 -- Premier Diagnostic Health Services Inc. ("PDH") (CNSX: PDH) today announced that it is extending its January 24, 2013 offering to accredited investors.

The previously announced offering consists of Convertible Debentures which will mature on July 31, 2016 (if not otherwise converted) and bear interest at a rate of 8% per annum payable on July 31 and December 31 each year during the Term or the earlier of Conversion or Maturity. The Debentures are convertible into common shares of the Company ("Common Shares") at any time prior to Maturity, in whole or in part, at the option of the holder, at a conversion rate of $0.18 per share. The Company shall have the right, on 30 days' notice, to redeem all or any portion of the Principal plus accrued Interest due on the Debentures. Holders have the right to convert during the 30 day notice period.

This extended offering will now expire at 2:00 p.m. on June 30, 2013. The company may carry out periodic closings during the term of the offering.

The proceeds of the Offering will be used to implement the Company's business plan, which includes funding China expansion, listing on a senior market and general corporate purposes. The Debentures and Common Shares issuable upon conversion of the Debentures will be subject to a four-month hold period from the date of closing.

More details about the business plan, term sheet, subscription form, and authorized representatives are available on the company's website at www.premierdiagnostics.ca. Please visit us on Facebook at www.facebook.com/petctscan.

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier. (Not for dissemination in the United States of America).

About Premier Diagnostic Health Services Inc. ("PDH")

Premier is a Canadian company accelerating international access to advanced medical diagnostic tools and skills. The company's vision is to provide services and partnership opportunities that support "improving medical decisions" around the world. The company's approach involves building long-term relationships covering management, quality, and financial services that are necessary to build, operate, and grow hospitals' diagnostic capacity and capability.

The Canadian National Stock Exchange has neither approved nor disapproved the contents of this press release.



Contacts:
Premier Diagnostic Health Services Inc.
Daniel Waters
Investor Relations
(604) 678.9120 Ext. 236
(604) 678.9278 (FAX)
dwaters@premierdiagnostics.ca
www.premierdiagnostics.ca

Premier Diagnostic Health Services Inc.
For Investment Purposes Contact - Aggie Klepl
(604) 678.9120 Ext. 232
(604) 678.9278 (FAX)
aggiek@hotmail.com
www.premierdiagnostics.ca





Source: Marketwire


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters